E25.0 Billable / specific Congenital adrenogenital disorders associated with enzyme deficiency
ICD-10-CM E25.0 identifies “Congenital adrenogenital disorders associated with enzyme deficiency” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 4: Endocrine, nutritional and metabolic diseases
Code-level instructions
Inclusion terms3
- Congenital adrenal hyperplasia
- 21-Hydroxylase deficiency
- Salt-losing congenital adrenal hyperplasia
Inherited instructions
Chapters 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E20-E35 · Disorders of other endocrine glands (E20-E35)
E25 · Adrenogenital disorders
Includes7
- adrenogenital syndromes, virilizing or feminizing, whether acquired or due to adrenal hyperplasia consequent on inborn enzyme defects in hormone synthesis
- Female adrenal pseudohermaphroditism
- Female heterosexual precocious pseudopuberty
- Male isosexual precocious pseudopuberty
- Male macrogenitosomia praecox
- Male sexual precocity with adrenal hyperplasia
- Male virilization (female)
Excludes 12
- indeterminate sex and pseudohermaphroditism (Q56)
- chromosomal abnormalities (Q90-Q99)
Official index references
Official index references (23)
Adrenogenital syndrome (2)
- Adrenogenital syndrome › congenitalDisease index
- Adrenogenital syndrome › salt lossDisease index
Adrenogenitalism, congenital (1)
- Adrenogenitalism, congenitalDisease index
Defect, defective (3)
- Defect, defective › 3-beta-hydroxysteroid dehydrogenaseDisease index
- Defect, defective › 11-hydroxylaseDisease index
- Defect, defective › 21-hydroxylaseDisease index
Deficiency, deficient (3)
- Deficiency, deficient › 3-beta hydroxysteroid dehydrogenaseDisease index
- Deficiency, deficient › 11-hydroxylaseDisease index
- Deficiency, deficient › 21-hydroxylaseDisease index
Hyperadrenocorticism (1)
- Hyperadrenocorticism › congenitalDisease index
Hyperfunction (1)
Hyperplasia, hyperplastic (5)
- Hyperplasia, hyperplastic › adrenal(capsule) (cortex) (gland) › with › sexual precocity(male) › congenitalDisease index
- Hyperplasia, hyperplastic › adrenal(capsule) (cortex) (gland) › with › virilism, adrenal › congenitalDisease index
- Hyperplasia, hyperplastic › adrenal(capsule) (cortex) (gland) › with › virilization(female) › congenitalDisease index
- Hyperplasia, hyperplastic › adrenal(capsule) (cortex) (gland) › congenitalDisease index
- Hyperplasia, hyperplastic › adrenal(capsule) (cortex) (gland) › congenital › salt-losingDisease index
Macrogenitosomia(adrenal) (male) (praecox) (1)
Masculinization(female) with adrenal hyperplasia (1)
Precocity, sexual(constitutional) (cryptogenic) (female) (idiopathic) (male) (1)
Pseudohermaphroditism (1)
- Pseudohermaphroditism › female › adrenal(congenital)Disease index
Syndrome (1)
Virilism(adrenal) (1)
- Virilism(adrenal) › congenitalDisease index
Virilization(female) (suprarenal) (1)
- Virilization(female) (suprarenal) › congenitalDisease index
References from other codes (4)
Excludes 1 · congenital adrenal hyperplasia (E25.0)
Excludes 1 · congenital adrenal hyperplasia (E25.0)
Excludes 1 · congenital adrenal hyperplasia (E25.0)
Excludes 1 · congenital adrenal hyperplasia (E25.0)
History
Code history
No recorded change since first observation
Effective from
- First observed
Congenital adrenogenital disorders associated with enzyme deficiency
Billable diagnosis code
CDC/NCHS · FY2016All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Historical ICD-9 mappings · 2018
Historical mapping only; not an automatic code substitution.
- 255.2 · Approximate
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.